Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
08/2010
08/11/2010EP2214645A2 Liposomal vancomycin formulations
08/11/2010EP1911763B1 Compositions for the treatment of gastrointestinal disorders
08/11/2010EP1303300B1 Compositions and methods for treatment of candidiasis
08/11/2010CN201542233U Multifunctional shape-protecting health care medical pillow for babies
08/11/2010CN1899430B Large size Qingkailing dripping pill and its preparing method
08/11/2010CN1840162B Compound total extract of compound cape jasmine, ginger and fermented soybean, its preparation and use
08/11/2010CN101801392A Compositions comprising lipoteichoic acid for use in treating pleural effusion or pneumothorax
08/11/2010CN101801387A compositions comprising quinolone and methods for treating or controlling infections
08/11/2010CN101801378A Novel combination of therapeutic agents
08/11/2010CN101801376A Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors
08/11/2010CN101798347A Monoclonal antibody for resisting high mobility group protein B1
08/11/2010CN101798305A Tetrahydronaphthyridine derivates useful as histamine h3 receptor ligands
08/11/2010CN101797379A Combination humidifying liquor for ultrasonic atomization therapy
08/11/2010CN101797374A Compound minocycline hydrochloride soluble powder for treating respiratory diseases of poultry
08/11/2010CN101797372A Fire-friend cold capsule
08/11/2010CN101797354A General prescription for treating dampness and heat (dampness and heat antidote and dampness and heat drying agent)
08/11/2010CN101797350A Traditional Chinese medicine for treating aged cough and preparation method thereof
08/11/2010CN101797343A Chinese medicinal formula for treating oral cavity and throat diseases
08/11/2010CN101797336A Granule preparation for treating cold and preparation method thereof
08/11/2010CN101797318A Medicament for treating tracheitis and preparation method thereof
08/11/2010CN101797297A Infantile inflammation diminishing and asthma relieving external application powder
08/11/2010CN101797295A Medicinal composition for treating infantile cough and preparation method thereof
08/11/2010CN101797277A Method for detecting Jingan capsule
08/11/2010CN101797271A Cleaning method of cordyceps sinensis
08/11/2010CN101797258A Medicine composition containing oral glucocorticoid and oral bronchodilator
08/11/2010CN101797253A Bergenin and cetirizine dihydrochloride compound oral administration preparation
08/11/2010CN101485673B Roxithromycin and ambroxol hydrochloride dispersible tablets
08/11/2010CN101352419B Acebrophylline sugar-free type granular formulation and preparation method thereof
08/11/2010CN101301476B Hydrophobic cyclodextrin clathrate and preparation and use thereof
08/11/2010CN101199739B Chinese medicine for oral administration for treating bronchus asthma
08/11/2010CN101176731B Application of asiatic acid in the aspect of resisting pulmonary fibrosis
08/11/2010CN101112602B Medicine for treating pharyngitis and method for preparing the same
08/11/2010CN101049345B A preparation for treating disease of oral cavity and gorge, and preparation method
08/11/2010CN101036684B Isatis-Root extractive and the purifying method and the medicine combination
08/11/2010CN101024004B Medicine composition for treating respiratory tract system diseases and its preparation process
08/10/2010US7772434 salt formation to form N-{2-[4-((R)-2-hydroxy-2-phenylethylamino)phenyl]ethyl}-(R)-2-hydroxy-2-(3-formamido-4-hydroxyphenyl)ethylamine monohydrochloride; pulmonary disease asthma or chronic obstructive pulmonary disease; administration by inhalation; crystal forms
08/10/2010US7772386 immunization against Mycobacterium tuberculosis; purified nucleic acid molecule coding for oxidoreductase from M. tuberculosis; production of a vaccine against a virulent strain of M. tuberculosis
08/10/2010US7772249 Imidazo[1,2-b]pyridazine compound
08/10/2010US7772236 Substituted pyrazoles
08/10/2010US7772228 Administering a rifamycin microbiocides for treating infections caused by Mycobacterium tuberculosis, Mycobacterium avium complex, Chlamydia pneumoniae or Helicobacter pylori
08/10/2010US7772198 cycstic fibrosis transmembrane conductance regulators (CFTR); for treatment of cystic fibrosis, asthma or diarrhea
08/10/2010US7771757 For topical application and saturation of portions of sinus physiology, comprising water, zinc acetate, alkaloids; plant extract of grapefruit seed; for therapy of cold or flu
08/10/2010CA2483159C Triazole derivatives as tachykinin receptor antagonists
08/10/2010CA2473680C Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
08/10/2010CA2467013C Substituted benzopyrans as selective estrogen receptor-beta agonists
08/10/2010CA2451452C Cyclic diamine compound with condensed-ring groups
08/10/2010CA2447021C Pyridyl cyanoguanidine compounds
08/10/2010CA2440714C Pyrazolopyrimidines as therapeutic agents
08/10/2010CA2432175C Storage stable powder compositions of interleukin-4 receptor
08/10/2010CA2391832C Oral dosage forms
08/10/2010CA2389647C Isoxazole derivatives as phosphodiesterase vii inhibitors
08/10/2010CA2366800C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
08/10/2010CA2249542C Pyrazole derivatives, their preparation and their use in pharmaceuticals
08/05/2010WO2010088450A2 Methods for treating diseases associated with the modulation of serca
08/05/2010WO2010087430A1 N-acyl anthranilic acid derivative or salt thereof
08/05/2010WO2010087399A1 Urotensin-ii receptor antagonists
08/05/2010WO2010087313A1 Neurite elongation stimulator
08/05/2010WO2010087306A1 Anti-neurodegenerative disease agent
08/05/2010WO2010087244A1 Cyclic amino alcohol compound
08/05/2010WO2010087207A1 Low-molecular polysulfated hyaluronic acid derivative and medicine containing same
08/05/2010WO2010087150A1 Gastric acid secretion inhibitor, and potassium channel inhibitor
08/05/2010WO2010086638A1 Dimeric pyrrolopyrimidinedione and its use in therapy of respiratory diseases
08/05/2010WO2010086530A1 Use of a synergistic combination of hypothiocyanite and/or hypohalite ions and lactoferrin for preparing a treatment for cystic fibrosis
08/05/2010WO2010086403A1 Azetidines as histamine h3 receptor antagonists
08/05/2010WO2010086387A1 5-ht4 inhibitors for treating airway diseases, in particular asthma
08/05/2010WO2010066909A3 New inhibitors for treating diseases associated with an excess transport of hyaluronan
08/05/2010WO2010053580A3 Reducing the risk of smoke-related disease
08/05/2010WO2010040862A3 New activators for treating and/or preventing diseases or medical conditions which benefit from an increased transport of hyaluronan across a lipid bilayer
08/05/2010WO2010039260A3 Spiperone derivatives and methods of treating disorders
08/05/2010WO2003060149A9 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/05/2010US20100197918 2,4-pyrimidinediamine compounds and their uses
08/05/2010US20100197917 Coumarin derivatives useful as tnf alpha inhibitors
08/05/2010US20100197907 Phosphorus-containing compounds & uses thereof
08/05/2010US20100197763 RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)
08/05/2010US20100197756 Indole-3-Sulphur Derivatives
08/05/2010US20100197745 Gamma-glutamyl transpeptidase inhibitors and methods of use
08/05/2010US20100197719 Medicament compositions containing anticholinergically-effective compounds and betamimetics
08/05/2010US20100197708 Indole compounds
08/05/2010US20100197693 Novel benzenesulfonamides as calcium channel blockers
08/05/2010US20100197689 Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives
08/05/2010US20100197673 Indole and indazole compounds as an inhibitor of cellular necrosis
08/05/2010US20100197665 Indazole derivatives as kinase inhibitors for the treatment of cancer
08/05/2010US20100197646 Solvent-based sterilisation of pharmaceuticals
08/05/2010US20100197644 Chemical Compounds 572
08/05/2010US20100197613 Methods for inhibition of nkt cells
08/05/2010US20100197608 Use of melanotrophin-potentiating factor as a therapeutic agent
08/05/2010US20100197607 Mucin hypersecretion inhibitors and methods of use
08/05/2010US20100197605 Therapeutic use of peptide yglf and combination with kvlpvpq
08/05/2010US20100197604 Use of peptide as a therapeutic agent
08/05/2010US20100197602 Use of follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumoniae infection
08/05/2010US20100197601 Use of a fibrinogen receptor antagonist and/or follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumonia infection
08/05/2010US20100197599 Use of a peptide as a therapeutic agent
08/05/2010US20100197588 Use of a peptide as a therapeutic agent
08/05/2010US20100197587 Use of a peptide as a therapeutic agent
08/05/2010US20100197586 Use of secretin and optionally urodilatin as therapeutic agents
08/05/2010US20100197585 Use of a rgd-peptide and/or parathyroid hormone (1-34) as anti-hiv agent
08/05/2010US20100197572 Use of somatostatin-14 as a therapeutic agent
08/05/2010US20100197562 Functionally selective alpha2c adrenoreceptor agonists
08/05/2010US20100196496 Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
08/05/2010US20100196476 Process for the preparation and pharmaceutical formulations for 4-quinolinones and quinolines and use thereof
1 ... 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 ... 878